Investor Kit

Company Profile

Founded in 1995, Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.

Acorda has an industry leading pipeline of novel neurological therapies addressing a range of disorders, including Parkinson's disease, migraine and multiple sclerosis. Acorda markets two FDA-approved therapies, including INBRIJA™ (levodopa inhalation powder).

Stock Chart

Financials

Date Filing Description Download
03/12/19 4 Statement of Changes in Beneficial Ownership
03/12/19 4 Statement of Changes in Beneficial Ownership
03/12/19 4 Statement of Changes in Beneficial Ownership
03/12/19 4 Statement of Changes in Beneficial Ownership

Stock Quote

ACOR (Common Stock) $ 14.45 +0.06 (+0.42%) Volume: 208,170 MORE March 19, 2019

Email Alerts

Un-subscribe from email alerts
Email Address *
Mailing Lists *





 
Enter the code shown above.